Glyc-A

1 paper1 finding

Human trial1

Interventions

1

Pemvidutide

downin humans1

1 study

Pemvidutide decreases Glyc-A in humans.
“Reductions in Glyc-A, a biomarker correlated with heart failure, were also observed”
Human trialsubcutaneous48 weeksn = 254
Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight
ADA Scientific Sessions 2025 abstract13 Jun 2025

More on Pemvidutide

Latest

ADA Scientific Sessions 2025 Abstract13 Jun

Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight

Randomised trial in 391 peopleOverweight